Hospital-level variation in practices and outcomes for patients with severe acute exacerbations of idiopathic pulmonary fibrosis: a retrospective multicentre cohort study.
Divya A ShankarAllan J WalkeyFinn J HawkinsNicholas A BoschDaniel PetersonAnica C LawPublished in: BMJ open respiratory research (2023)
We observed high variation in the use of IMV and NIMV, and less variation in corticosteroid and immunosuppressant and/or antioxidant use among patients hospitalised with severe IPF exacerbations. Further research is needed to guide the decisions surrounding initiation of IMV and role of NIMV and to understand the effectiveness of corticosteroids among patients with severe IPF exacerbations.
Keyphrases
- idiopathic pulmonary fibrosis
- chronic obstructive pulmonary disease
- cystic fibrosis
- interstitial lung disease
- healthcare
- early onset
- randomized controlled trial
- systematic review
- oxidative stress
- anti inflammatory
- cross sectional
- study protocol
- emergency department
- type diabetes
- acute care
- adipose tissue
- double blind